Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 346 AL 360

COVID-19 and Alzheimer's disease: how one crisis worsens the other

Xia X, Wang Y, Zheng J.

Transl Neurodegener. 2021 Apr 30;10(1):15. doi: 10.1186/s40035-021-00237-2.

Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review

Massett HA, Mitchell AK, Alley L, Simoneau E, Burke P, Han SH, Gallop-Goodman G, McGowan M.

J Alzheimers Dis. 2021;82(1):107-127. doi: 10.3233/JAD-201463.

The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1

de la Torre JC, Gonzalez-Lima F.

J Alzheimers Dis. 2021;82(3):881-882. doi: 10.3233/JAD-210736.

The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA

Karlawish J, Grill JD.

Nat Rev Neurol. 2021 Sep;17(9):523-524. doi: 10.1038/s41582-021-00540-6.

Medicare Should Not Cover Aducanumab as a Treatment for Alzheimer's Disease

Moghavem N, Henderson VW, Greicius MD.

Ann Neurol. 2021 Sep;90(3):331-333. doi: 10.1002/ana.26167. Epub 2021 Aug 10.

The Present State of Lithium for the Prevention of Dementia Related to Alzheimer's Dementia in Clinical and Epidemiological Studies: A Critical Review

Ishii N, Terao T, Hirakawa H.

Int J Environ Res Public Health. 2021 Jul 22;18(15):7756. doi: 10.3390/ijerph18157756.

Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis

Martinkova J, Quevenco FC, Karcher H, Ferrari A, Sandset EC, Szoeke C, Hort J, Schmidt R, Chadha AS, Ferretti MT.

JAMA Netw Open. 2021 Sep 1;4(9):e2124124. doi: 10.1001/jamanetworkopen.2021.24124.

Impressive reddish nodules with neoplastic-like appearance in a patient with Alzheimer's disease

Siragusa M, Lentini M, Schepis C.

Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):300-302. doi: 10.4103/ijdvl.IJDVL_226_19.

Critical Review of the Alzheimer's Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?

Flores-Cuadra JA, Madrid A, Fernández PL, Pérez-Lao AR, Oviedo DC, Britton GB, Carreira MB.

J Alzheimers Dis. 2021;82(s1):S227-S250. doi: 10.3233/JAD-200870.

Use of subcutaneous ketamine to rapidly improve severe treatment-resistant depression in a patient with Alzheimer's disease

Rocha FL, de Vasconcelos Cunha UG, Paschoalin RC, Hara C, Thomaz DP.

Int Clin Psychopharmacol. 2021 Mar 1;36(2):104-105. doi: 10.1097/YIC.0000000000000334.

Retinal Optical Coherence Tomography Metrics Are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy

Sergott RC, Raji A, Kost J, Sur C, Jackson S, Locco A, Patel A, Furtek C, Mattson B, Egan MF.

J Alzheimers Dis. 2021;79(1):275-287. doi: 10.3233/JAD-200735.

Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer Disease

Musiek ES, Morris JC.

JAMA Neurol. 2021 Feb 1;78(2):141-142. doi: 10.1001/jamaneurol.2020.4478.

Effect of Antihypertensive Drugs on Cognition and Behavioral Symptoms of Patients with Alzheimer's Disease: A Meta-analysis

Rahimi R, Nikfar S, Sadeghi M, Abdollahi M, Moghaddam RH, Farzaei MH.

Curr Pharm Biotechnol. 2021;22(11):1511-1519. doi: 10.2174/1386207323666201211101720.

Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease

Ettcheto M, Busquets O, Cano A, Sánchez-Lopez E, Manzine PR, Espinosa-Jimenez T, Verdaguer E, Sureda FX, Olloquequi J, Castro-Torres RD, Auladell C, Folch J, Casadesús G, Camins A.

J Alzheimers Dis. 2021;82(s1):S91-S107. doi: 10.3233/JAD-201106.

Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab

Klein G, Delmar P, Kerchner GA, Hofmann C, Abi-Saab D, Davis A, Voyle N, Baudler M, Fontoura P, Doody R.

J Prev Alzheimers Dis. 2021;8(1):3-6. doi: 10.14283/jpad.2020.68.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias